380.00
3.00 (0.80%)
Market Trend
Short Term | Medium Term | ||
Industry | Diagnostics & Research (US) | Mixed | Mixed |
Diagnostics & Research (Global) | Mixed | Mixed | |
Stock | Medpace Holdings, Inc. | Bearish | Bullish |
Stockmoo Score
Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical-device firms. It also offers ancillary services such as bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has over 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati and its operations are principally based in the us, but it also operates in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018. |
|
Sector | Healthcare |
Industry | Diagnostics & Research |
Investment Style | Mid Growth |
Ownership
Name | Date | Shares Held |
---|---|---|
Westwind Capital | 30 Jun 2024 | 380,929 |
52 Weeks Range | ||
Price Target Range | ||
High | 434.00 (TD Cowen, 14.21%) | Buy |
Median | 430.00 (13.16%) | |
Low | 336.00 (Deutsche Bank, -11.58%) | Hold |
Average | 409.40 (7.74%) | |
Total | 3 Buy, 2 Hold | |
Avg. Price @ Call | 382.54 |
Firm | Date | Target Price | Call | Price @ Call |
---|---|---|---|---|
Truist Securities | 01 Aug 2024 | 415.00 (9.21%) | Hold | 385.16 |
Baird | 24 Jul 2024 | 430.00 (13.16%) | Buy | 381.88 |
08 Jul 2024 | 469.00 (23.42%) | Buy | 405.64 | |
Deutsche Bank | 24 Jul 2024 | 336.00 (-11.58%) | Hold | 381.88 |
Guggenheim | 24 Jul 2024 | 432.00 (13.68%) | Buy | 381.88 |
TD Cowen | 24 Jul 2024 | 434.00 (14.21%) | Buy | 381.88 |
No data within this time range.
Date | Type | Details |
---|---|---|
22 Jul 2024 | Announcement | Medpace Holdings, Inc. Reports Second Quarter 2024 Results |
26 Jun 2024 | Announcement | Medpace Holdings, Inc. to Report Second Quarter 2024 Financial Results on July 22, 2024 |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
Realized Profit | - |
Unrealized Profit | - |
Dividend Received 2024 | - |
Total Profit | - |
Avg. Return | - |
Quantity (Buy) | - |
Avg. Price (Buy) | - |
Quantity (Sold) | - |
Avg. Price (Sold) | - |